Neuroinflammation and Mitochondrial Dysfunction in Parkinson’s Disease: Connecting Neuroimaging with Pathophysiology

There is a pressing need for disease-modifying therapies in patients suffering from neurodegenerative diseases, including Parkinson’s disease (PD). However, these disorders face unique challenges in clinical trial designs to assess the neuroprotective properties of potential drug candidates. One of...

Descripción completa

Detalles Bibliográficos
Autores principales: Pizarro-Galleguillos, Benjamin Matís, Kunert, Liesa, Brüggemann, Norbert, Prasuhn, Jannik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375976/
https://www.ncbi.nlm.nih.gov/pubmed/37507950
http://dx.doi.org/10.3390/antiox12071411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375976/
https://www.ncbi.nlm.nih.gov/pubmed/37507950
http://dx.doi.org/10.3390/antiox12071411

Ejemplares similares